Calibration of CTS5 in Women With Early Estrogen Receptor-Positive Breast Cancer

Affiliations

¹ Mitch Dowsett, PhD, Ralph Lauren Centre for Breast Cancer Research, Royal Marden Hospital, London, UK and Ivana Sestak, PhD and Jack Cuzick, PhD, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

Comment

Mitch Dowsett et al. J Clin Oncol. 2021.

. 2021 Feb 1;39(4):338-339.

doi: 10.1200/JCO.20.02551. Epub 2020 Dec 16.

¹ Mitch Dowsett, PhD, Ralph Lauren Centre for Breast Cancer Research, Royal Marden Hospital, London, UK and Ivana Sestak, PhD and Jack Cuzick, PhD, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

No abstract available

Comment in

Reply to M. Dowsett et al.
Noordhoek I, Putter H, Portielje JEA, Liefers GJ. Noordhoek I, et al. J Clin Oncol. 2021 Feb 1;39(4):339-340. doi: 10.1200/JCO.20.03015. Epub 2020 Dec 16. J Clin Oncol. 2021. PMID: 33326259 No abstract available.

Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials.
Noordhoek I, Blok EJ, Meershoek-Klein Kranenbarg E, Putter H, Duijm-de Carpentier M, Rutgers EJT, Seynaeve C, Bartlett JMS, Vannetzel JM, Rea DW, Hasenburg A, Paridaens R, Markopoulos CJ, Hozumi Y, Portielje JEA, Kroep JR, van de Velde CJH, Liefers GJ. Noordhoek I, et al. J Clin Oncol. 2020 Oct 1;38(28):3273-3281. doi: 10.1200/JCO.19.02427. Epub 2020 Jul 24. J Clin Oncol. 2020. PMID: 32706636